###### Strengths and limitations of this study

-   This is the first study in which the role of cytokines in relation to insulin sensitivity is examined in immigrants from the Middle East as well as in the native population of Swedes.

-   The main limitation of our study is the relatively small sample size, which means any ethnic differences need to be confirmed in a larger population. However, it should be noted that the study was conducted as a hypothesis-generating study.

Introduction {#s1}
============

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder caused by defects in insulin secretion, insulin action or both. If ineffectively controlled, the resulting chronic hyperglycaemia is associated with numerous disabling complications.[@R1] The prevalence of T2DM and related conditions is increasing worldwide, and it is estimated that by 2025, 15% of the world\'s population will have T2DM, impaired fasting glucose (IFG) or impaired glucose tolerance (IGT).[@R2]

In Sweden, the prevalence of T2DM among non-European immigrants is estimated to be 2--3 times higher than among native Swedes.[@R3] In addition, previous research has shown that onset of T2DM occurs 10 years earlier in immigrants from the Middle East than native Swedes, and Middle Eastern immigrants diagnosed with T2DM more frequently have a family history of T2DM.[@R4]

The main mechanisms of insulin resistance in T2DM are oxidative stress, endoplasmic reticulum stress, amyloid deposition in the pancreas, ectopic lipid deposition in the muscle, liver and pancreas, and lipotoxicity and glucotoxicity.[@R5] [@R6] Although it is difficult to determine which mechanism is the most important, among those with T2DM these processes can be caused by overnutrition. It is important to note, however, that each of these stresses could either induce an inflammatory response or be associated with inflammation.[@R7] [@R8]

The association between inflammation and insulin resistance and future development of T2DM has been shown previously.[@R9] [@R10] The production of tumour necrosis factor (TNF)-α by cells in the adipose tissue of rodents provided early evidence of a link between tissue inflammation and the pathogenesis of insulin resistance and T2DM.[@R11] In addition, interleukin (IL)-1β contributes to the glucose-induced impairment of β-cell function and apoptosis.[@R12]

Family history and a sedentary lifestyle are highly prevalent risk factors for T2DM in immigrants from the Middle East.[@R4] [@R13] Obesity is another major risk factor for T2DM that is also highly prevalent among immigrants from the Middle East.[@R13] Obesity is associated with low-grade chronic inflammation, which activates the innate immune system. This activation leads to the release of proinflammatory cytokines such as TNF-α, IL-1β and IL-6, which disrupt insulin homeostasis by blocking major anabolic cascades downstream of insulin signalling.[@R10] Elevated levels of proinflammatory cytokines may thus characterise the early preclinical stages of T2DM.[@R14; @R15; @R16]

Even though the association between high levels of cytokines and insulin resistance has been well studied, few studies have been performed to elucidate the roles of inflammatory markers in various ethnic groups. In one such study from the USA, circulating TNF-α levels were found to differ according to ethnicity, with Hispanics having the highest levels and African Americans the lowest.[@R17]

Characterising inflammatory markers in the population groups at highest risk of developing T2DM is important in the prediction of disease onset and the evaluation of strategies for disease prevention. The aim of this study was to investigate the relationship between cytokines and insulin sensitivity in two ethnically different groups: residents of the Swedish city of Malmö who were born in Sweden and Iraq. To our knowledge, this is the first study of its kind in which profiles of as many as 10 cytokines were analysed in two ethnic groups.

Material and methods {#s2}
====================

Subjects {#s2a}
--------

Male and female residents in the Rosengård residential area of Malmö, aged 45--65 years and born in Sweden (Swedes) or Iraq (Iraqis), were randomly selected from the census register. We chose the ages 45--65 years since that was the age group of the non-retired population with the highest probability of identifying individuals with prediabetes or diabetes, since the prevalence of diabetes increases with age. In total, 296 individuals were invited to participate. The study was performed according to the declaration of Helsinki.[@R18] Written informed consent was given by all the participants in the study after full explanation of the purpose and nature of all procedures used.

Clinical variable assessment {#s2b}
----------------------------

Body mass index (BMI) was calculated as weight (kg) divided by height (m^2^). Abdominal obesity was defined as waist circumference of ≥102 cm for men and ≥88 cm for women.[@R19] Leisure time physical activity was classified into four categories as described previously.[@R13] Individuals in categories 2--4 were considered physically active while those in category 1 were considered sedentary. Systolic and diastolic blood pressure was measured twice in the supine position after 5 min rest. The mean of the two measurements was calculated.

A standard of 75 g oral glucose tolerance test (OGTT) was performed and blood glucose was measured in blood samples collected at 0, 30, 60 and 120 min by a HemoCue photometer (HemoCue AB, Ängelholm, Sweden).[@R20] Insulin sensitivity index (ISI) was calculated from the OGTT data as described previously.[@R21] Participants were asked not to eat after 22:00 the day before the sample collection. Normal glucose tolerance (NGT) was defined as a fasting plasma glucose (0 h sample) level of \<6.1 mmol/L and a plasma glucose level of \<7.8 mmol/L 2 h after having been given 75 g glucose in the OGTT.[@R22] IFG was defined as a fasting plasma glucose level of ≥6.1 mmol/L and \<7 mmol/L and a 2 h glucose level of \<7.8 mmol/L. An IGT test was defined as either a fasting plasma glucose level of ≥6.1 mmol/L and \<7 mmol/L and/or a 2 h glucose level of ≥7.8 mmol/L and \<11.1 mmol/L. T2DM was defined as fasting plasma glucose level of ≥7 mmol/L and/or OGTT of ≥11.1 mmol/L.[@R22] Hyperglycaemia was defined as patients with IFG, IGT or T2DM. Serum insulin levels were determined using the radioimmunoassay technique (Access Ultrasensitive Insulin, Beckman Coulter, USA).[@R23]

Cholesterol and triglycerides were analysed using enzymatic methods, whereas high-density lipoprotein (HDL)-cholesterol was measured after isolation of low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL; Boehringer Mannheim GmbH, Germany) and LDL cholesterol was analysed using Friedewald\'s method.[@R24]

C reactive protein (CRP) was measured by a commercial kit from Roche diagnostics, according to the manufacturer\'s instructions.

Sample preparation and quantification of cytokines {#s2c}
--------------------------------------------------

Samples were collected into a 3.5 mL serum separating tube and were allowed to clot for 1 h at room temperature. They were then centrifuged for 10 min at 4°C and serum was aliquoted and stored at −80°C for further use. The Bio-Plex Precision Pro Human Cytokine 10-Plex Panel (Bio-Rad Inc, Hercules, California, USA), a high-sensitivity Luminex-based magnetic bead assay, was used to quantify IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, interferon (IFN)-γ and TNF-α in serum according to the manufacturer\'s instructions. In brief, samples were diluted 1:4 in the sample diluent provided with the kit and incubated with magnetic beads coupled to specific antibodies. Cytokines were detected with premixed detection antibody. Beads were read on a Bio-Plex Suspension Array System and the data were analysed using Bio-Plex Manager software (V.4.0). Absolute concentrations were measured from a standard curve generated from eight serially diluted standards provided with the kit. Each sample was analysed in duplicate. Values are presented in pg/ml. Each run included controls of known concentration for each cytokine and a blank. Detection limits for IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IFN-γ and TNF-α were 0.14, 0.6, 0.16, 0.87, 0.44, 0.37, 0.13, 0.31, 0.3 and 0.13 pg/mL, respectively. Interassay coefficient of variation was between 6.2 and 13.3 (values were calculated from six different experiments).

Statistical analysis {#s2d}
--------------------

Differences in sample characteristics between Swedish-born participants and first-generation immigrants from Iraq were tested using Student\'s t test for continuous variables, χ² tests for dichotomous variables and the Wilcoxon rank-sum test for the variables with a non-normal distribution ([table 1](#BMJOPEN2013003473TB1){ref-type="table"}). Distribution of all cytokines is presented with median and IQR and tested with the Wilcoxon rank-sum test ([table 2](#BMJOPEN2013003473TB2){ref-type="table"}). [Tables 1](#BMJOPEN2013003473TB1){ref-type="table"} and [2](#BMJOPEN2013003473TB2){ref-type="table"} were also adjusted for age, sex and BMI and adjusted p values were calculated using linear regression for continuous variables, logistic regression for dichotomous variables, ordered logistic regression for normal/impaired/T2D and rank analysis of covariance[@R25] for variables with non-normal distribution.

###### 

Baseline anthropometric and metabolic characteristics of the study population by country of birth

  Covariate                          Iraq (n=73)   Sweden (n=62)   p Value   Adjusted p value\*
  ---------------------------------- ------------- --------------- --------- --------------------
  Sex (female/male)†                 48/52         45/55           0.75      0.63
  Age (years)‡                       54 (5.9)      57 (5.4)        0.01      0.002
  BMI (kg/m^2^)‡                     29 (4.1)      27 (4.4)        0.007     0.002
  Waist circumference (cm)‡§         98 (12)       97 (12)         0.87      0.54
  Sedentary lifestyle (yes/no)†      71/29         57/43           0.10      0.20
  Family history (yes/no)†           59/41         25/75           0.0002    0.004
  Systolic BP (mm Hg)‡               129 (19)      141 (22)        0.0008    0.004
  Diastolic BP (mm Hg)‡              81 (12)       88 (12)         0.003     0.008
  ISI¶                               84 (56)       104 (77)        0.04      0.51
  Normoglycaemia\\IFG or IGT\\T2D†   64/30/5       65/31/5         0.99      0.89
  Fasting glucose (mmol/L)‡          5.7 (0.9)     5.8 (0.9)       0.43      0.53
  2 h Glucose (mmol/L)‡              7.1 (2.8)     6 (2.6)         0.02      0.02
  Serum insulin (pmol/L)†            8 (5)         7 (4)           0.22      0.79
  HbA1c (%)‡\*\*                     4.9 (0.6)     4.9 (0.8)       0.95      0.63
  LDL (mmol/L)‡                      3.5 (0.8)     3.7 (1.0)       0.36      0.61
  HDL (mmol/L)‡                      1.1 (0.3)     1.3 (0.5)       0.001     0.002
  Triglycerides (mmol/L)¶            1.4 (1.0)     1.0 (1.1)       0.02      0.24
  C-peptide (mmol/L)¶                0.6 (0.3)     0.6 (0.3)       0.65      0.08
  C reactive protein (mg/L)‡         3.6 (2.9)     3.4 (2.7)       0.71      0.74

\*Adjusted for sex, age and BMI.

†Sex, sedentary lifestyle, hyperglycaemia and family history are presented as percentages.

‡Age, BMI, cholesterol, LDL, HDL, HbA1c, systolic and diastolic BP, waist circumference, C reactive protein, fasting glucose and 2 h glucose are presented as the mean and SD.

§Adjusted for sex and age.

¶ISI, triglycerides and C-peptide are presented as the median and IQR.

\*\*HbA1c is presented as mean in IFCC units (NGSP units).

BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; HbA1c; glycated haemoglobin; IGT, impaired glucose tolerance; IFG, impaired fasting glucose; ISI, insulin sensitivity index; LDL, low-density lipoprotein; T2D, type 2 diabetes.

###### 

Concentration of cytokine levels, stratified by country of birth

                All (n=135)   Iraq (n=73)   Sweden (n=62)          
  ------------- ------------- ------------- --------------- ------ ------
  IL-1β         0.94 (0.77)   0.94 (0.98)   0.94 (0.67)     0.78   0.88
  IL-2          6.25 (4.93)   5.78 (4.83)   6.55 (4.93)     0.72   0.66
  IL-4          0.69 (0.58)   0.72 (0.72)   0.69 (0.47)     0.44   0.70
  IL-5          7.96 (6.95)   8.28 (7.82)   7.95 (6.78)     0.47   0.43
  IL-6          1.26 (6.38)   1.62 (6.76)   0 (5.22)        0.32   0.40
  IL-10         6.89 (6.58)   7.26 (7.15)   6.41 (5.2)      0.51   0.68
  IL-12 (p70)   1.14 (1.14)   1.21 (1.15)   1.04 (1.10)     0.76   0.82
  IL-13         2.05 (1.54)   2.06 (1.66)   2.01 (1.43)     0.39   0.59
  IFN-γ         2.81 (2.48)   2.79 (2.6)    2.82 (2.11)     0.47   0.47
  TNF-α         0.65 (0.68)   0.67 (0.78)   0.65 (0.64)     0.34   0.38

\*Values are shown in pg/mL.

†p Value for test between Iraq and Sweden.

‡Adjusted for sex, age and BMI.

BMI, body mass index; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumour necrosis factor-α.

Linear regression was used to examine the associations between cytokine levels and ISI. Natural log transformation of ISI was used to obtain an approximately normal distribution. IL-5, IL-12 (p70), IFN-γ and TNF-α were transformed with a natural log function due to their highly skewed distribution. IL-6 was dichotomised into below detection limit (\<0.44 pg/mL) values and above detection limits (≥0.44), due to nearly 50% of values being below detection limit. It was possible to include the other cytokines untransformed. First, univariate analysis was performed to assess the association of each cytokine with ISI in the whole sample. Thereafter, multivariate linear regression was performed with ISI as the dependent variable and with adjustment for BMI and/or waist circumference, age, sex, sedentary lifestyle and family history of T2DM ([table 3](#BMJOPEN2013003473TB3){ref-type="table"}). All analyses were then stratified by country of birth to examine whether the associations differed between individuals born in Sweden and those born in Iraq ([table 4](#BMJOPEN2013003473TB4){ref-type="table"}). The associations were also examined by including an interaction term between each cytokine and country of birth in the multivariate linear regression model (see online supplementary table). To test the robustness of the results from the regression models, we repeated the analysis with dichotomisation of all the cytokines. STATA V.12 (Stata Corp LP) was used for all statistical analyses.

###### 

Multivariate linear regression of the whole study population with logarithmic insulin sensitivity index as the dependent variable and cytokine level as the exposure

  Cytokines†    Unadjusted   Adjusted\*                                     
  ------------- ------------ ------------ ---------------- ------- -------- ----------------
  IL-1β         −0.24        \<0.01       −0.39 to −0.08   −0.23   0.01     −0.39 to −0.07
  IL-2          −0.04        \<0.01       −0.07 to −0.01   −0.04   \<0.01   −0.07 to −0.02
  IL-4          −0.30        \<0.01       −0.50 to −0.11   −0.27   0.01     −0.48 to −0.06
  IL-5          −0.16        0.02         −0.30 to −0.02   −0.20   0.01     −0.35 to −0.06
  IL-6          −0.27        0.01         −0.46 to −0.08   −0.26   0.01     −0.45 to −0.07
  IL-10         −0.03        0.01         −0.05 to −0.01   −0.03   \<0.01   −0.05 to −0.01
  IL-12 (p70)   −0.21        0.07         −0.44 to 0.02    −0.28   0.02     −0.51 to −0.04
  IL-13         −0.14        \<0.01       −0.22 to −0.05   −0.12   0.01     −0.21 to −0.03
  IFN-γ         −0.21        0.03         −0.41 to −0.02   −0.20   0.05     −0.40 to 0.00
  TNF-α         −0.32        0.05         −0.65 to 0.00    −0.41   0.03     −0.77 to −0.04

\*IL-1β, IL-2, IL-4, IL-10 and IL-13 were used untransformed; IL-5, IL-12 (p70), IFN-γ and TNF-α were ln-transformed; and IL-6 was dichotomised into below (\<0.44 pg/mL) and above (≥0.44) detection limits.

†Covariates in the models: age, sex, BMI, sedentary lifestyle and family history.

BMI, body mass index; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumour necrosis factor-α.

###### 

Multivariate linear regression by country of birth with logarithmic insulin sensitivity index as the dependent variable and cytokine level as the exposure

  Cytokines†    Iraq    Sweden                                                                                                     
  ------------- ------- -------- ---------------- ------- -------- ---------------- ------- ------ ---------------- ------- ------ ---------------
  IL-1β         −0.30   \<0.01   −0.50 to −0.10   −0.36   \<0.01   −0.59 to −0.13   −0.11   0.35   −0.35 to 0.13    −0.13   0.25   −0.36 to 0.10
  IL-2          −0.06   \<0.01   −0.09 to −0.02   −0.06   \<0.01   −0.09 to −0.02   −0.02   0.27   −0.06 to 0.02    −0.03   0.14   −0.06 to 0.01
  IL-4          −0.36   0.01     −0.61 to −0.10   −0.47   \<0.01   −0.77 to −0.16   −0.17   0.25   −0.47 to 0.13    −0.10   0.53   −0.40 to 0.21
  IL-5          −0.28   0.01     −0.49 to −0.07   −0.36   \<0.01   −0.60 to −0.12   −0.04   0.65   −0.22 to 0.14    −0.07   0.48   −0.25 to 0.12
  IL-6          −0.24   0.08     −0.51 to 0.03    −0.37   0.01     −0.67 to −0.08   −0.27   0.05   −0.54 to −0.01   −0.25   0.05   −0.50 to 0.00
  IL-10         −0.04   0.01     −0.07 to −0.01   −0.04   \<0.01   −0.07 to −0.01   −0.02   0.38   −0.05 to 0.02    −0.01   0.38   −0.05 to 0.02
  IL-12 (p70)   −0.40   0.01     −0.71 to −0.10   −0.47   0.01     −0.82 to −0.11   0.02    0.92   −0.31 to 0.34    −0.09   0.57   −0.42 to 0.23
  IL-13         −0.17   \<0.01   −0.28 to −0.06   −0.18   \<0.01   −0.30 to −0.06   −0.05   0.52   −0.18 to 0.09    −0.04   0.53   −0.18 to 0.09
  IFN-γ         −0.32   0.02     −0.59 to −0.05   −0.38   0.01     −0.68 to −0.08   −0.06   0.68   −0.32 to 0.21    −0.06   0.65   −0.33 to 0.21
  TNF-α         −0.36   0.09     −0.77 to 0.06    −0.73   0.01     −1.26 to −0.21   −0.14   0.59   −0.67 to 0.39    −0.26   0.31   −0.78 to 0.25

\*Covariates in the models: age, sex, BMI, sedentary lifestyle and family history.

†IL-1β, IL-2, IL-4, IL-10 and IL-13 were used untransformed; IL-5, IL-12 (p70), IFN-γ and TNF-α were ln-transformed; and IL-6 was dichotomised into below (\<0.44 pg/mL) and above (≥0.44) detection limits.

BMI, body mass index; IFN-γ, interferon-γ; IL, interleukin; TNF-α, tumour necrosis factor-α.

Results {#s3}
=======

Baseline characteristics of the study population {#s3a}
------------------------------------------------

Of the total number of invited participants, 194 (Iraqi, n=107; Swedish, n=87) agreed to participate and were included in the study between 1 February and 31 March 2010. Patients who had already been diagnosed with T2DM and those who could not participate in an OGTT (Iraqi, n=24; Swedish, n=13) were excluded from the study. Nineteen participants dropped out (Iraqi, n=11; Swedish, n=8). Those who had a cold/fever (n=3) at the time of blood sampling were not included in the analyses. In total, 135 individuals were included (Iraqi, n=73; Swedes, n=62) in the analyses. [Table 1](#BMJOPEN2013003473TB1){ref-type="table"} shows the anthropometric and metabolic characteristics of the study participants born in Iraq and Sweden. Consistent with earlier reported data from the same population-based study,[@R13] median ISI was higher in the Swedes than in the Iraqis. Swedes were older and had lower BMI than Iraqis. Mean HDL levels were higher in Swedes than in Iraqis, whereas triglyceride levels were higher in Iraqis than in Swedes. The prevalence of family history of T2DM was significantly higher in Iraqis than in Swedes. Mean systolic and diastolic blood pressures were higher in Swedes than in Iraqis. Iraqis had higher levels of 2 h glucose levels than Swedes. However, after adjusting for age, sex and BMI, differences in ISI and triglycerides between Iraqis and Swedish did not remain significant. There were no significant differences in sex, waist circumference, sedentary lifestyle, NGT, IGT or T2DM, fasting glucose, fasting serum insulin, glycated haemoglobin, LDL, triglycerides, C-peptide and levels of CRP between the two groups ([table 1](#BMJOPEN2013003473TB1){ref-type="table"}). Sixty-four per cent Iraqi and 65% Swedes had NGT, 30% Iraqis and 31% Swedes had IGT and 5% each were diagnosed with T2DM in Swedes and Iraqis.

Expression of cytokines {#s3b}
-----------------------

[Table 2](#BMJOPEN2013003473TB2){ref-type="table"} shows expressions of cytokines (median and IQRs) in the whole population and in the two ethnic groups. There were no significant differences in median values between study participants born in Iraq and Sweden before as well as after adjusting for age, sex and BMI.

Association between cytokines and ISI {#s3c}
-------------------------------------

In the overall population, univariate analysis showed that, with the exception of IL-12 (p70; p=0.07), the levels of all analysed cytokines had significant (p≤0.05) inverse associations with ISI ([table 3](#BMJOPEN2013003473TB3){ref-type="table"}). Interestingly, after adjusting for age, sex, BMI, sedentary lifestyle and family history of T2DM, levels of all analysed cytokines remained inversely associated with ISI (p≤0.05; [table 3](#BMJOPEN2013003473TB3){ref-type="table"}). Stratification of the data according to ethnicity showed strong inverse associations between levels of IL-1β, IL-2, IL-4, IL-5, IL-10, IL-12 (p70), IL-13 and IFN-γ (p≤0.02) and ISI in Iraqis ([table 4](#BMJOPEN2013003473TB4){ref-type="table"}). After adjustment for age, sex, BMI, sedentary lifestyle and family history of T2DM, all 10 tested cytokines remained significantly associated with ISI in the Iraqi population (p≤0.01; [table 4](#BMJOPEN2013003473TB4){ref-type="table"}). Subanalysis of IL-6 and TNF-α by separately entering age, sex, BMI, sedentary life style and family history of T2DM in the model showed that sedentary life style and family history of T2DM were associated with ISI, IL-6 and TNF-α (data not shown). In contrast, in the Swedes, no cytokine, except IL-6 (p=0.05), was significantly associated with ISI in the univariate analysis and after adjusting for age, sex, BMI, sedentary life style and family history of T2DM ([table 4](#BMJOPEN2013003473TB4){ref-type="table"}). Changing the variable BMI to the variable waist circumference gave almost identical p values and β-values (data not shown). Interestingly, not only did the p values differ between Iraqi and Swedes, but all β-values were also higher in Iraqis than in Swedes, even after adjusting for age, sex, BMI, sedentary life style and family history of T2DM (eg, β=−0.73 for TNF-α in Iraqis compared with −0.26 in Swedes, [table 4](#BMJOPEN2013003473TB4){ref-type="table"}). We also repeated the analysis with all cytokines dichotomised with the 75th centile as cut-off in the regression models; the results remained almost identical (data not shown). In the interaction tests, we found no significant difference in associations between Iraqis and Swedish participants (see online [supplementary table](http://bmjopen.bmj.com/lookup/suppl/doi:10.1136/bmjopen-2013-003473/-/DC1)).

Discussion {#s4}
==========

For the first time, the expression of a panel of 10 cytokines in Swedish-born and Iraqi-born populations and their associations with insulin sensitivity was investigated. We found that levels of all 10 cytokines included in this study were strongly associated with lower insulin sensitivity in Iraqis, after controlling for age, sex, BMI, sedentary lifestyle and family history of T2DM. These findings were not observed among the Swedes.

Ethnic differences do exist in the prevalence of T2DM and its complications[@R26]; however, no previous study has investigated the inflammatory response in Middle Eastern immigrants as well as in native Scandinavians. The prevalence of T2DM in the immigrant population in Sweden has been shown to be higher than that in native Swedes.[@R3] A large proportion of the immigrants in Sweden are from the Middle East, and Iraqis constitute one of the largest immigrant group in Sweden and the largest immigrant population living in Malmö. Consistent with our results, a previous study of patients born in the Middle East and Sweden suggests that patients born in the Middle East have earlier T2DM onset, higher BMI and higher prevalence of family history of T2DM than Swedish-born patients with T2DM.[@R4]

Low-grade systemic inflammation results in insulin resistance, to which pancreatic islets respond by enhancing their cell mass and thereby their insulin secretory activity. However, exhaustion of this mechanism leads to insulin deficiency and ultimately T2DM.[@R27] Elevated levels of cytokines such as IL-6 and TNF-α have been associated with T2DM in other ethnic groups.[@R28] As described previously in the same population, Iraqis have a lower insulin sensitivity than Swedes.[@R13] However, it is not known whether cytokines have any role in this difference. Our results show that high levels of all cytokines analysed in this study (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 (p70), IL-13, IFN-γ and TNF-α) were independently associated with lower insulin sensitivity in immigrants from Iraq, whereas high levels of only IL-6 were found to be associated with lower insulin sensitivity in Swedes. Obesity increases proinflammatory cytokine levels in the circulation and peripheral tissues. Iraqi participants had higher BMI values than the Swedes.[@R13] However, the association between cytokines and insulin resistance in the Iraqi population was found to be independent of BMI, suggesting that the association between cytokines and insulin resistance was not due to the higher BMI values in the Iraqis. There was no difference in waist circumference between the two groups.

It has been reported that it is not the general adiposity but rather visceral fat that is associated with the incidence of prediabetes and T2DM.[@R29] In fact, ectopic fat deposition in the abdominal viscera has been shown to be a more important mediator of diabetes development than the total fat mass in obese individuals.[@R30] High visceral and hepatic fat levels have been associated with higher levels of IL-6[@R31] and IL-8,[@R32] respectively. We did not measure visceral or hepatic fat in our study population to prove this assumption. However, we adjusted our data with waist circumference used as a proxy for visceral fat, but it did not explain the association between insulin resistance and cytokines in Iraqis (data not shown). Impaired glucose levels have been associated with higher level of inflammation, which eventually leads to insulin resistance.[@R33] Source of increased circulating levels of cytokines in T2DM seems to originate from non-circulating cells such as adipocytes and endothelial cells.[@R34] Furthermore, higher glucose levels increases the secretion of cytokines from cultured human endothelial cells.[@R35] Iraqis are known to have higher IGT levels. Therefore, it is possible that the major source of secreted cytokines in Iraqis may not be adipocytes and it can be speculated that the association between cytokines and insulin resistance in Iraqis is due to higher blood glucose level which leads to increase in inflammatory process, independent of obesity.

The main limitation of our study is the small sample and few observations, which means that the results need to be confirmed in a larger population. However, it should be noted that it was conducted as a hypothesis-generating study.

In conclusion, we have for the first time examined cytokine levels in Iraqi-born and Swedish-born residents of Sweden in relation to insulin sensitivity. We found an inverse association between cytokines and insulin sensitivity in Iraqis but not in Swedes. This association was independent of sex, BMI, age, sedentary lifestyle or prevalence of family history of T2DM. However, further investigations on larger population samples are required to establish potential differences in associations between population groups.
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